The potential role of ERβ isoforms in the clinical management of breast cancer

被引：19

作者：

Green, C. A. ^{[2
]}

Peter, M. B. ^{[2
]}

Speirs, V. ^{[2
]}

Shaaban, A. M. ^{[1
]}

机构：

[1] St James Univ Hosp, St Jamess Inst Oncol, Dept Histopathol & Mol Pathol, Leeds LS9 7TF, W Yorkshire, England

[2] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England

来源：

HISTOPATHOLOGY | 2008年 / 53卷 / 04期

关键词：

breast cancer; ER beta isoforms; oestrogen receptors; prognosis; tamoxifen;

D O I：

10.1111/j.1365-2559.2008.02968.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The discovery of a second oestrogen receptor, ER beta, was a subject of much interest, as this suggested a means to improve the prognostic stratification of invasive breast cancer, better predict response to endocrine therapy, develop new chemotherapeutic/chemopreventative drugs and perhaps prevent inappropriate treatment. However, this has not proved to be straightforward with the discovery of five ER beta isoforms and numerous exon deletion variants. This review sets out to identify the present state of knowledge regarding the clinicopathological role of ER beta isoforms and discusses possible reasons for conflicting results arising from recent research findings.

引用

收藏

页码：374 / 380

页数：7

相关论文

共 55 条

[21]

MCGUIRE WL, 1975, CANCER, V36, P638

[22] Estrogen receptor-β potency-selective ligands:: Structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues [J].

Meyers, MJ ;

Sun, J ;

Carlson, KE ;

Marriner, GA ;

Katzenellenbogen, BS ;

Katzenellenbogen, JA .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) :4230-4251

[23] Cloning and characterization of human estrogen receptor β isoforms [J].

Moore, JT ;

McKee, DD ;

Slentz-Kesler, K ;

Moore, LB ;

Jones, SA ;

Horne, EL ;

Su, JL ;

Kliewer, SA ;

Lehmann, JM ;

Willson, TM .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (01) :75-78

[24] ER beta: Identification and characterization of a novel human estrogen receptor [J].

Mosselman, S ;

Polman, J ;

Dijkema, R .

FEBS LETTERS, 1996, 392 (01) :49-53

[25] Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells [J].

Murphy, LC ;

Peng, B ;

Lewis, A ;

Davie, JR ;

Leygue, E ;

Kemp, A ;

Ung, K ;

Vendetti, M ;

Shiu, R .

JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2005, 34 (02) :553-566

[26] The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer [J].

Nakopoulou, L ;

Lazaris, AC ;

Panayotopoulou, EG ;

Giannopoulou, I ;

Givalos, N ;

Markaki, S ;

Keramopoulos, A .

JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (05) :523-528

[27] Wild-type oestrogen receptor beta (ERb1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers [J].

O'Neill, PA ;

Davies, MPA ;

Shaaban, AM ;

Innes, H ;

Torevell, A ;

Sibson, DR ;

Foster, CS .

BRITISH JOURNAL OF CANCER, 2004, 91 (09) :1694-1702

[28] Molecular cloning and characterization of human estrogen receptor βcx:: a potential inhibitor of estrogen action in human [J].

Ogawa, S ;

Inoue, S ;

Watanabe, T ;

Orimo, A ;

Hosoi, T ;

Ouchi, Y ;

Muramatsu, M .

NUCLEIC ACIDS RESEARCH, 1998, 26 (15) :3505-3512

[29] Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers [J].

Omoto, Y ;

Kobayashi, S ;

Inoue, S ;

Ogawa, S ;

Toyama, T ;

Yamashita, H ;

Muramatsu, M ;

Gustafsson, JÅ ;

Iwase, H .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (03) :380-386

[30] The expression of ERβcx in human breast cancer and the relationship to endocrine therapy and survival [J].

Palmieri, C ;

Lam, EWF ;

Mansi, J ;

MacDonald, C ;

Shousha, S ;

Madden, P ;

Omoto, Y ;

Sunters, A ;

Warner, M ;

Gustafsson, JÅ ;

Coombes, RC .

CLINICAL CANCER RESEARCH, 2004, 10 (07) :2421-2428

← 1 2 3 4 5 6 →